Beam Therapeutics Inc. (BEAM)

SEC filing

Beam Therapeutics Inc.

BEAM · CIK 1745999

4 · Oct 16, 2026 · Director, CEO Evans John M. sold 50K shares at $23.77/share ($1.2M); exercised options for 100K shares

Director, CEO Evans John M. sold 50K shares at $23.77/share ($1.2M); exercised options for 100K shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).